| scholarly article | Q13442814 |
| P50 | author | Te-Chun Hsieh | Q42174677 |
| P2093 | author name string | Chia-Hung Kao | |
| Yu-Chin Wu | |||
| Kuo-Yang Yen | |||
| Shung-Shung Sun | |||
| P2860 | cites work | Management of hepatocellular carcinoma: An update | Q27860530 |
| Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives | Q28081783 | ||
| ⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments | Q28083830 | ||
| Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma | Q28264065 | ||
| Cancer statistics, 2005 | Q29617572 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study | Q33691454 | ||
| Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma | Q34089023 | ||
| Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting | Q34131801 | ||
| Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis | Q34585175 | ||
| Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 | ||
| Yttrium-90 microsphere radioembolization for hepatocellular carcinoma | Q35631304 | ||
| The blood supply of neoplasms in the liver | Q35930392 | ||
| Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study | Q36080209 | ||
| Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications | Q36287668 | ||
| Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. | Q36573194 | ||
| Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. | Q36673829 | ||
| Recent advances in transarterial therapy of primary and secondary liver malignancies | Q37060058 | ||
| Effect of portal vein embolisation on the growth rate of colorectal liver metastases | Q37123418 | ||
| Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. | Q37376714 | ||
| Radioembolization of liver tumors with yttrium-90 microspheres | Q37683830 | ||
| Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review | Q37885238 | ||
| Radioembolization for the treatment of liver tumors general principles. | Q37987948 | ||
| Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer. | Q38181308 | ||
| In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? | Q38984450 | ||
| Standardized liver volumetry for portal vein embolization | Q40086263 | ||
| Therapeutic strategies for hepatocellular carcinoma: new advances and challenges | Q41191439 | ||
| Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation | Q42601023 | ||
| Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients | Q43850818 | ||
| Analysis of radiation-induced liver disease using the Lyman NTCP model. | Q44048914 | ||
| Safety of repeated yttrium-90 radioembolization | Q44200845 | ||
| Tolerance of the liver to the effects of Yttrium-90 radiation | Q44257068 | ||
| Safety of 90Y radioembolization in patients who have undergone previous external beam radiation therapy | Q44628735 | ||
| Patient Selection and Activity Planning Guide for Selective Internal Radiotherapy With Yttrium-90 Resin Microspheres | Q44692003 | ||
| Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis | Q47819721 | ||
| Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. | Q51021204 | ||
| Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. | Q52927165 | ||
| Treatment of hepatocellular carcinoma | Q57757025 | ||
| Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma | Q58283601 | ||
| Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization | Q63198749 | ||
| Vascularization of small liver metastases | Q69089620 | ||
| Selective internal radiation therapy: distribution of radiation in the liver | Q69393442 | ||
| The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors | Q71383465 | ||
| Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors | Q71821807 | ||
| Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up | Q72729791 | ||
| Can current models explain the lack of liver complications in Y-90 microsphere therapy? | Q73131968 | ||
| Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer | Q73323825 | ||
| Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres | Q74256633 | ||
| A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization | Q84121312 | ||
| Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q84424049 | ||
| Safety of repeated radioembolizations in patients with advanced primary and secondary liver tumors and progressive disease after first selective internal radiotherapy | Q87270280 | ||
| Management of hepatocellular carcinoma | Q87664325 | ||
| P433 | issue | 4 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| microsphere | Q1759020 | ||
| P304 | page(s) | 19 | |
| P577 | publication date | 2016-11-16 | |
| P1433 | published in | BioMedicine | Q27725996 |
| P1476 | title | Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review | |
| P478 | volume | 6 |
| Q38601217 | Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan |
| Q47135473 | Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma |
| Q47139956 | Dipeptidyl Peptidase-4 Inhibitors Use and Relative Risk of Ischemic Cerebrovascular Disease in Type 2 Diabetic Patients in a Case-Control Study |
| Q46492850 | Increased Risk of Pulmonary Tuberculosis in Patients with Depression: A Cohort Study in Taiwan |
| Q90136078 | Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions |
| Q50198707 | Population-based cohort study investigating the correlation of diabetes mellitus with pleural empyema in adults in Taiwan |
| Q47623516 | Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan |
| Q41684501 | Use of Oral Corticosteroids and Risk of Hip Fracture in the Elderly in a Case-Control Study |
| Q46240389 | Zolpidem Administration and Risk of Hepatocellular Carcinoma: A Case-Control Study in Taiwan |
Search more.